INS Bioscience Berhad (INSBIO) Company Profile - CorporateInformation.com

Company Search:

Advanced Search

Wright Investors Service Perspectives


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

INS Bioscience Berhad Company Snapshot

Business Description:

INS Bioscience Berhad operates in the Commercial physical research sector. INS Bioscience Berhad is engaged in the businesses of research and development, consultancy in biotechnology and investment holding. The Company has three segments: manufacturing segment, which is engaged in manufacturing and sale of healthcare products; marketing and distribution of products, which is engaged in the distribution of healthcare products, and others segment, which is engaged in investment holding. The Company, through its subsidiaries, is engaged in marketing, distribution and e-business of products for local and international markets, manufacturing and processing of healthcare products, supplying of raw materials, and conducting research and development in bioscience technology, research and development of healthcare products and its distribution. Its subsidiaries include Easy Pha-Max Marketing Sdn. Bhd., The Origin Foods Sdn. Bhd. and Hopematic Sdn. Bhd. On August 19, 2011, the Company acquired Healthy More International Sdn. Bhd. In our complete report available for purchase the company is compared to: Vimta Labs Limited, Bioneer Corporation and Macrogen.

INS Bioscience Berhad

Stock Performance Chart for INS Bioscience Berhad

Stock Data:

Recent Stock Performance:

Current Price (2/10/2012): .17
(Figures in Malaysian Ringgits)

1 Week	0.0%		13 Weeks	9.7%

4 Weeks	3.0%		52 Weeks	-34.6%

INS Bioscience Berhad Key Data:

	Ticker:	INSBIO	Country:	MALAYSIA

	Exchanges:	KUL	Major Industry:	Drugs, Cosmetics & Health Care

			Sub Industry:	Diversified Drugs, Cosmetics, & Health Care

	2011 Sales	62,897,190 (Year Ending Jan 2012).	Employees:	130

	Currency:	Malaysian Ringgits	Market Cap:	48,626,565

	Fiscal Yr Ends:	March	Shares Outstanding:	286,038,620

	Share Type:	Ordinary	Closely Held Shares:	N/A

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.